Search PubMedSearch

PubMed · 9498923

[Memory traces in EEG].

Abstract

The paper gives a brief overview of five experimental approaches in which memory processes were studied by means of event-related brain potentials (ERPs). Some of the results were already published in English (Study 1), while others are new and will be reported in greater length as full paper elsewhere (Studies 2, 3, 4, and 5). Study 1 revealed that retrieval of information from episodic long-term memory is accompanied by a systematic slow negative potential. The topography of this slow wave depends on the quality of the reactivated information (spatial vs. verbal), and its amplitude reflects the difficulty of the retrieval process. In experiment 2 ERPs were recorded while subjects acquired either explicit or implicit knowledge about a sequential stimulus-response pattern. The data suggest that explicit learners who posses verbalizable knowledge about sequential dependencies have formed both perceptual and motor representations, while implicit learners have formed motor representations only. In study 3 fact retrieval in mental arithmetic was activated by a verification task. Incongruent solutions evoked an arithmetic N400-effect whose amplitude varied with the associative distance between an expected and an actually perceived solution to a multiplication problem. In study 4 ERPs were recorded during mental rotation tasks. A set of experiments revealed that mental rotation is always accompanied by a systematic negative variation over the parietal cortex. The amplitude of this "rotation specific negativity" increases with an increasing angular disparity between a perceived sign and its normal upright template. It was shown that this negativity is functionally distinct from a P300-complex which is often superimposed on it within the same latency window. Finally, study 5 examined ERPs in a sentence reading task in which grammatically legal but infrequent sentence constructions had to be processed. A left-anterior negativity was observed whenever an explicit case marker (the definite article in German) signalled a nominal phrase at a noncanonical position. The LAN phenomenon appears to be a manifestation of a syntax processor which performes a first-pass formal analysis of a sentence and which possibly allocates working memory resources whenever a word cannot be assigned immediately to an expected propositional role.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Rösler, J Bajrić, M Heil, E Hennighausen, M Niedeggen, T Pechmann, B Röder, J Rüsseler, J Streb. 1997. [Memory traces in EEG].. https://pubmed.ncbi.nlm.nih.gov/9498923/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain

Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.

OBJECTIVE: To investigate whether dopamine D2 and D3 receptor subtypes (D2/3Rs) outside the caudate-putamen are affected in PD. BACKGROUND: Alterations in striatal D2-like dopamine receptors in PD have been extensively demonstrated using PET, but there are no studies focusing on extrastriatal D2/3Rs. METHODS: Fourteen unmedicated patients with idiopathic early PD with predominantly left-sided symptoms, 14 levodopa-medicated patients with advanced PD, and 20 normal age-matched controls were examined using PET. PET scanning was performed with a novel high-affinity D2/3R radioligand ([11C]FLB 457) and a PET scanner in three-dimensional mode. RESULTS: In advanced PD, the binding potential of [11C]FLB 457 in the dorsolateral prefrontal cortex was decreased by 40% (p < 0.01), in the anterior cingulate cortex by 20% (p < 0.01), and in the medial thalamus by 17% (p < 0.05) compared with healthy controls. In early PD, the extrastriatal [11C]FLB 457 binding potentials were not significantly different compared with the control group. However, the binding potential in the anterior cingulate cortex (29%; p < 0. 05) was higher in early PD compared with advanced PD. CONCLUSIONS: These results imply that the D2/3 receptor subtypes outside the striatum are affected in advanced PD but not in the early stages of the disease, and that this receptor decline is present in the anterior cingulate cortex, the dorsolateral prefrontal cortex, and the thalamus.

Brain